Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection
- 1 November 1990
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 117 (5), 799-808
- https://doi.org/10.1016/s0022-3476(05)83348-7
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patientsThe Journal of Pediatrics, 1990
- Pediatric AIDS: Problems within ProblemsThe Journal of Infectious Diseases, 1990
- Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)Science, 1989
- Clinical and basic advances in the antiretroviral therapy of human immunodeficiency virus infectionAmerican Journal Of Medicine, 1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- Human immunodeficiency virus infection in childrenThe Journal of Pediatrics, 1989
- Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV InfectionNew England Journal of Medicine, 1988
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.Proceedings of the National Academy of Sciences, 1986